SONIC HEALTHCARE LIMITED (SHL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SHL - SONIC HEALTHCARE LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Sonic Healthcare is one of the world's largest medical diagnostics companies, providing laboratory and imaging services to medical practitioners, hospitals, community health services, and their collective patients. It was first listed in 1987.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$30.42

08 Dec
2022

-0.420

OPEN

$30.94

-1.36%

HIGH

$31.12

1,178,948

LOW

$30.42

TARGET
$35.195 15.7% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EBO . SLA . CAJ . GXL . HSO . MPL . MVF . NHF . HLS . RHC . VRT . MDR . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . BMT . NVL . AHX . ALC . ACL .
FNARENA'S MARKET CONSENSUS FORECASTS
SHL: 1
Title FY21
Actual		 FY22
Actual		 FY23
Forecast		 FY24
Forecast
EPS (cps) xxx 305.5 165.7 xxx
DPS (cps) xxx 100.0 100.9 xxx
EPS Growth xxx 10.9% - 45.8% xxx
DPS Growth xxx 9.9% 0.9% xxx
PE Ratio xxx N/A 18.2 xxx
Dividend Yield xxx N/A 3.3% xxx
Div Pay Ratio(%) xxx 32.7% 60.9% xxx

Dividend yield today if purchased 3 years ago: 3.40%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 3.31

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 06/09 - ex-div 60c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201720182019202020212022
EPS Basic xxxxxxxxxxxxxxx305.5
DPS All xxxxxxxxxxxxxxx100.0
Sales/Revenue xxxxxxxxxxxxxxx9,306.5 M
Book Value Per Share xxxxxxxxxxxxxxx1,542.1
Net Operating Cash Flow xxxxxxxxxxxxxxx2,225.8 M
Net Profit Margin xxxxxxxxxxxxxxx15.69 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201720182019202020212022
Return on Capital Employed xxxxxxxxxxxxxxx21.39 %
Return on Invested Capital xxxxxxxxxxxxxxx15.36 %
Return on Assets xxxxxxxxxxxxxxx11.51 %
Return on Equity xxxxxxxxxxxxxxx21.39 %
Return on Total Capital xxxxxxxxxxxxxxx21.20 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx1,483.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

18/11/2022

5

Underperform

$31.30

2.89%

Covid testing was always expected to ease for Sonic Healthcare but yesterday's trading update indicated the drop-off is more rapid than Macquarie had forecast. At the same time, there remains the risk of cost inflation.

Macquarie's earnings forecasts are below consensus and a sum-of-the-parts valuation highlights downside risk at current levels, the broker notes.

Underperform retained, target falls to $31.30 from $31.50.

FORECAST
Macquarie forecasts a full year FY23 dividend of 103.00 cents and EPS of 156.00 cents.
Macquarie forecasts a full year FY24 dividend of 106.00 cents and EPS of 142.00 cents.

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >

SHL STOCK CHART

FNArena News on SHL

1
Australian Broker Call *Extra* Edition – Dec 09, 2022

Dec 09 2022 - Daily Market Reports
2
Australian Broker Call *Extra* Edition – Nov 28, 2022

Nov 28 2022 - Daily Market Reports
3
Weekly Ratings, Targets, Forecast Changes – 25-11-22

Nov 28 2022 - Weekly Reports
4
Rudi’s View: Re-Opening Opportunities In Healthcare

Nov 17 2022 - Rudi's View
5
Australian Broker Call *Extra* Edition – Oct 28, 2022

Oct 28 2022 - Daily Market Reports

Latest Healthcare services News

1
No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022 - Australia
2
Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022 - Small Caps
3
Negative Industry Trends Impact Australian Clinical Labs

Aug 12 2022 - Small Caps
4
Healius Offers Digital Carrot, Base Remains Soft

May 25 2022 - Australia
5
Ramsay Stakes Future on Mental Health

Dec 20 2021 - Australia
6
Ramsay Health Care: Finally A Break-Out

Nov 09 2021 - Technicals
7
Funding Overhang Weighs On Ramsay’s Rebound

Jun 10 2021 - Australia
8
Treasure Chest: More Pfizer Growth For Ebos Group

May 24 2021 - Treasure Chest
9
Treasure Chest: Demand Pumps Ramsay Health

Mar 03 2021 - Treasure Chest
10
Healius Enjoying Testing Times

Dec 11 2020 - Australia